title: Pharmacologic characteristics of rabbit esophageal muscularis mucosae in vitro.
abstract: The aim of this study was to investigate in vitro the pharmacologic properties of rabbit esophageal muscularis mucosae. Stimulation of its motor innervation elicited only atropine-sensitive excitatory responses. This tissue was not refractory to histamine but appeared to be rapidly desensitized to its effects. Responses to adrenoreceptor agonists were produced by excitatory alpha1 and beta1 adrenoreceptors, inhibitory beta3 receptors but not alpha2 receptors. The esophageal muscularis mucosae was only weakly stimulated by neurokinins and bradykinin, and these responses were mediated via NK2, NK3, B1, and B2 receptors, respectively. Adenosine diphosphate and adenosine triphosphate produced approximately 40% maximal contractions through the activation of P2 receptors, whereas adenosine monophosphate and adenosine were without effect. Responses to prostaglandins E2 and F2alpha were < or =10% of the tissues' maximum response to acetylcholine. These data demonstrate that rabbit esophageal muscularis mucosae has a simple excitatory innervation and is only weakly stimulated by a variety of pharmacologic agents. For these reasons it is distinct from muscularis mucosae found elsewhere in the rabbit gastrointestinal tract.
authors.affiliation: Department of Physiology and Pharmacology, School of Medicine, The University of South Dakota, Vermillion 57069-2390, USA.
authors.forename: W H
authors.initials: WH
authors.lastname: Percy
authors.forename: A J
authors.initials: AJ
authors.lastname: Miller
authors.forename: J T
authors.initials: JT
authors.lastname: Brunz
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000322:Adrenergic Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D004558:Electric Stimulation; D004947:Esophagus / Q000187:drug effects* / Q000502:physiology; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D011983:Receptors, Purinergic / Q000187:drug effects; D013373:Substance P / Q000494:pharmacology
chemical_list: D000322:Adrenergic Agonists; D000318:Adrenergic beta-Agonists; D011453:Prostaglandins; D011983:Receptors, Purinergic; D013373:Substance P; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D006632:Histamine; D000255:Adenosine Triphosphate; D011433:Propranolol; D000241:Adenosine; D007545:Isoproterenol; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine; D010646:Phentolamine